157 related articles for article (PubMed ID: 28436028)
21. Anti-p200/laminin γ1 pemphigoid associated with metastatic oesophageal cancer.
Goetze S; Dumke AK; Zillikens D; Hipler UC; Elsner P
J Eur Acad Dermatol Venereol; 2017 Apr; 31(4):e219-e221. PubMed ID: 27684497
[No Abstract] [Full Text] [Related]
22. Usefulness of a Simple Immunohistochemical Staining Technique to Differentiate Anti-p200 Pemphigoid From Other Autoimmune Blistering Diseases: A Report of 2 Cases.
García-Díez I; Martínez-Escala ME; Ishii N; Hashimoto T; Mascaró Galy JM; Pujol RM; Herrero-González JE
Actas Dermosifiliogr; 2017; 108(1):e1-e5. PubMed ID: 27095685
[TBL] [Abstract][Full Text] [Related]
23. A case of anti-p200 pemphigoid with autoantibodies against both a novel 200-kD dermal antigen and the 290-kD epidermolysis bullosa acquisita antigen.
Furukawa H; Miura T; Takahashi M; Nakamura K; Kaneko F; Ishii F; Komai R; Hashimoto T
Dermatology; 2004; 209(2):145-8. PubMed ID: 15316171
[TBL] [Abstract][Full Text] [Related]
24. Case of anti-p200 pemphigoid accompanying uterine malignancy.
Hayashi M; Okamura K; Ujiie H; Iwata H; Suzuki T
J Dermatol; 2018 Dec; 45(12):e341-e342. PubMed ID: 29766559
[No Abstract] [Full Text] [Related]
25. Bullous pemphigoid in a 3-month-old infant after vaccination.
Cortés-Pinto C; Baradad Brusau M; Vilardell Vilellas F; Mascaró Galy JM; Arco Huguet N; Soria Gili X
Clin Exp Dermatol; 2019 Apr; 44(3):341-343. PubMed ID: 30267442
[No Abstract] [Full Text] [Related]
26. Bullous Pemphigoid in Infancy Showing Epitope-spreading Phenomenon: Recovery with Topical Therapy.
Matsuda H; Oiso N; Ishii N; Sato M; Tatebayashi M; Hashimoto T; Kawada A
Acta Derm Venereol; 2015 May; 95(5):610-1. PubMed ID: 25424244
[No Abstract] [Full Text] [Related]
27. Anti-laminin 5 pemphigoid: a case report of a benign cutaneous confined non-cicatricial variant.
Magro CM; Wu R
Int J Dermatol; 2012 Jan; 51(1):79-85. PubMed ID: 21790553
[No Abstract] [Full Text] [Related]
28. Treatment of anti-laminin γ1 pemphigoid with mycophenolate mofetil.
Gawaz A; Metzler G; Hertl M; Hashimoto T; Schaller M
J Dtsch Dermatol Ges; 2015 Jul; 13(7):696-7. PubMed ID: 26058852
[No Abstract] [Full Text] [Related]
29. Anti-p200 pemphigoid.
Goletz S; Hashimoto T; Zillikens D; Schmidt E
J Am Acad Dermatol; 2014 Jul; 71(1):185-91. PubMed ID: 24767733
[TBL] [Abstract][Full Text] [Related]
30. Dyshidrosiform palmoplantar pemphigoid in a young man: response to dapsone.
Lupi F; Masini C; Ruffelli M; Puddu P; Cianchini G
Acta Derm Venereol; 2010; 90(1):80-1. PubMed ID: 20107732
[No Abstract] [Full Text] [Related]
31. Subepidermal blistering disease with autoantibodies to both the p200 autoantigen and the alpha3 chain of laminin 5.
Shimanovich I; Petersen EE; Weyers W; Sitaru C; Zillikens D
J Am Acad Dermatol; 2005 May; 52(5 Suppl 1):S90-2. PubMed ID: 15858518
[TBL] [Abstract][Full Text] [Related]
32. Dipeptidyl peptidase-4 inhibitor-associated anti-laminin-γ1 (p200) pemphigoid in a patient with psoriasis vulgaris.
Minakawa S; Matsuzaki Y; Hashimoto T; Ishii N; Nishie W; Kayaba H; Sawamura D
J Dermatol; 2020 Jan; 47(1):e25-e26. PubMed ID: 31646656
[No Abstract] [Full Text] [Related]
33. Immunoglobulin G deposition to nonhemidesmosomal lamina lucida and early neutrophil involvement are characteristic features in a case of anti-p200 pemphigoid.
Shimizu A; Funakoshi T; Ishibashi M; Yoshida T; Koga H; Hashimoto T; Amagai M; Ishiko A
Br J Dermatol; 2013 Mar; 168(3):647-55. PubMed ID: 22963596
[TBL] [Abstract][Full Text] [Related]
34. Anti-laminin γ1 pemphigoid accompanied by autoantibodies to laminin α3 and γ2 subunits of laminin-332.
Kamata M; Fujita H; Hamanaka T; Takahashi K; Koga H; Hashimoto T; Sato S
JAMA Dermatol; 2013 Dec; 149(12):1437-9. PubMed ID: 24154702
[No Abstract] [Full Text] [Related]
35. The proteolytic effect of bromelain on bullous pemphigoid antigen-2.
Belcher MD; Kaddour-Djebbar I; Bollag WB; Davis LS
J Am Acad Dermatol; 2016 Oct; 75(4):838-840. PubMed ID: 27646744
[No Abstract] [Full Text] [Related]
36. An attempt to develop mouse model for anti-laminin γ1 pemphigoid.
Koga H; Ishii N; Dainichi T; Tsuruta D; Hamada T; Ohata C; Karashima T; Furumura M; Hashimoto T
J Dermatol Sci; 2013 May; 70(2):108-15. PubMed ID: 23410740
[TBL] [Abstract][Full Text] [Related]
37. Anti-laminin gamma-1 pemphigoid.
Dainichi T; Kurono S; Ohyama B; Ishii N; Sanzen N; Hayashi M; Shimono C; Taniguchi Y; Koga H; Karashima T; Yasumoto S; Zillikens D; Sekiguchi K; Hashimoto T
Proc Natl Acad Sci U S A; 2009 Feb; 106(8):2800-5. PubMed ID: 19196964
[TBL] [Abstract][Full Text] [Related]
38. Anti-p200 Pemphigoid: A Systematic Review.
Kridin K; Ahmed AR
Front Immunol; 2019; 10():2466. PubMed ID: 31695695
[TBL] [Abstract][Full Text] [Related]
39. Bullous pemphigoid with IgG autoantibodies to the α3 subunit of laminin 332 associated with psoriasis vulgaris.
Ohashi M; Takagi H; Mizutani Y; Seishima M; Koga H; Hashimoto T
Eur J Dermatol; 2017 Jun; 27(3):306-307. PubMed ID: 28468743
[No Abstract] [Full Text] [Related]
40. Relapse-associated autoantibodies to BP180 in a patient with anti-p200 pemphigoid.
Kasperkiewicz M; Hoppe U; Zillikens D; Schmidt E
Clin Exp Dermatol; 2010 Aug; 35(6):614-7. PubMed ID: 19874345
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
